Trial Details

Not Recruiting
Basic Information
Clinical ID c3078
Identifier EUCTR2011-004561-33-AT
Trial Title A randomized, controlled, single-blinded, phase II study to investigate the safety and efficacy of intravenous infusions of FERINJECT versus placebo on platelet activity in patients with iron deficiency and chronic inflammatory bowel disease. The ThromboAct trial - ThromboAct
Trial URL Visit Original Page
Study Information
Study Results

Yes
Conditions iron deficiency in chronic inflammatory bowel disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: Ferinject Product Name: Ferinject Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: ferric carboxymaltose CAS Number: 9007-72-01 Current Sponsor code: Vifor int Other descriptive name: ferinject Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 50- Pharmaceutical form of the placebo: Solution for infusion Route of administration of the placebo: Intravenous use
Participant Information
Sponsor Medizinische Universit Wien, Klinik f Innere Medizin III, Abteilung f Gastroenterologie und Hepatologie
City -
Country/Region Austria
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE2
Time Information
Start Date 2025-04-24
Primary Completion Date 2021-03-19
Completion Date 2016-09-06